Fierce Pharma

APRIL 30, 2024

The U.S. Federal Trade Commission (FTC) is not done with its crackdown on what it views as improper listing of patents with the FDA. | The U.S. FTC is not done with its crackdown on what it views as improper listing of patents in the FDA Orange Book. After an initial round of challenge launched in November against more than 100 patents, the FTC is back targeting another 300-plus patent listings by eight pharma firms.

FDA 292

FDA Pharma 292

MedCity News

APRIL 30, 2024

Enlaza Therapeutics’ drugs form covalent bonds that lock the therapy onto its target. With cancer as its initial focus, the startup contends its approach could offer safety and efficacy advantages compared to currently available targeted therapies. The post J.P. Morgan Leads $100M Financing for Startup’s R&D of Covalent Biologic Drugs for Cancer appeared first on MedCity News.

Leads 121

Leads Safety Biopharma Pharma 121

Fierce Pharma

APRIL 30, 2024

Biopharma companies and industry lobbying groups are striking out in their legal efforts to challenge price-cutting measures in the Inflation Reduction Act. | A federal judge tossed lawsuits by Bristol Myers Squibb and Johnson & Johnson, which questioned the constitutionality of the U.S. government requiring drugmakers to negotiate with Medicare on drug pricing.

Biopharma 286

Biopharma Government 286

MedCity News

APRIL 30, 2024

The Drug Enforcement Agency’s decision to reclassify cannabis to a Schedule III drug could mark the first step in a long process to establish a new normal for medical cannabis care. The post Momentum is Building to Put Medical Cannabis into Mainstream Healthcare appeared first on MedCity News.

Medical 113

Medical Healthcare Healthcare 113

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

APRIL 30, 2024

Besides the diabetes and obesity duo of Mounjaro and Zepbound, the SGLT2 inhibitor Jardiance and the CDK4/6 cancer drug Verzenio were cited as the main growth drivers for Eli Lilly’s first quarter. | Besides the diabetes and obesity duo of Mounjaro and Zepbound, the SGLT2 inhibitor Jardiance and the CDK4/6 cancer drug Verzenio were cited as the main growth drivers for Eli Lilly’s first quarter.

241

241

pharmaphorum

APRIL 30, 2024

For the last few years, Walmart has been promising to disrupt the US healthcare sector with a national network of clinics providing low-cost care and telehealth services. Now, it is reining back on those plans.

Healthcare 122

Healthcare Healthcare Networking 122

MedCity News

APRIL 30, 2024

In this month’s episode, Senior Reporter Katie Adams explored some executive hires and exits that recently occurred in the healthcare world, as well as layoffs affecting the industry. She also interviewed Adaeze Enekwechi, who became CEO of Cayaba Care this month. The post MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Adaeze Enekwechi, CEO of Cayaba Care appeared first on MedCity News.

Healthcare 102

Healthcare Healthcare 102

Fierce Pharma

APRIL 30, 2024

With WuXi AppTec’s very existence under threat from proposed biosecurity legislation in the U.S., the Chinese CDMO giant is standing its ground on its quest to preserve its business and “do the rig | With WuXi AppTec’s very existence under threat from proposed biosecurity legislation in the U.S., the Chinese CDMO giant is standing its ground on its quest to preserve its business and “do the right thing,” the company’s CEO, Ge Li, said in the company’s first-quarter earnings report.

Sales 219

Sales 219

European Pharmaceutical Review

APRIL 30, 2024

The Committee for Human Medicinal Products (CHMP) has recommended the approval of new eight medicines. A positive opinion of a marketing authorisation was granted for Altuvoct (efanesoctocog alfa), as a treatment and prophylaxis of bleeding in patients with the rare blood disorder haemophilia A. Last week, the US FDA approved a new gene therapy for eligible adults with haemophilia B.

Medicine 98

Medicine Consulting Patients FDA 98

Fierce Pharma

APRIL 30, 2024

UK's Centre for Process Innovation plots cloud-first manufacturing plant as part of digital collaboration with AZ, GSK and more fkansteiner Tue, 04/30/2024 - 10:01

Manufacturing 205

Manufacturing 205

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

Pharmaceutical Technology

APRIL 30, 2024

Dengue fever is now found in over 120 countries compared to nine that experienced severe epidemics in the 1970s given the spread of infectious diseases due to climate change.

98

98

European Pharmaceutical Review

APRIL 30, 2024

What are the top three trends that you are seeing in the biopharma manufacturing space? Vikas Gupta (VG): In the years preceding the Covid pandemic, the ATMP s market, including both the innovators as well as the contract development and manufacturing organisations (CDMOs), was a bit too optimistic about its growth prospects as it was building significant manufacturing capacity focusing primarily on viral vectors.

Manufacturing 97

Manufacturing Food and Drug Administration Biopharma Marketing 97

MedCity News

APRIL 30, 2024

A great deal of healthcare can take place in the home, leaving valuable bandwidth available for specialized facilities when they are needed. The post Home Health: A Solution to Skyrocketing Healthcare Costs appeared first on MedCity News.

Healthcare 98

Healthcare Healthcare Specialization 98

European Pharmaceutical Review

APRIL 30, 2024

Researchers in Germany have developed an technique to increase the speed of spectroscopic analysis , which typically takes from minutes to hours to acquire measurement. [the technique] can greatly accelerate data acquisition in ultrafast spectroscopy, particularly in higher-dimensional analyses” According to the paper published in the Journal of Ultrafast Science , the innovative technique “can greatly accelerate data acquisition in ultrafast spectroscopy, particularly in higher-dimensiona

Doctors 97

Doctors Pharmaceutical 97

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

pharmaphorum

APRIL 30, 2024

California will start selling its own generic of overdose reversal agent naloxone in another example of the use of government-level purchasing power to reduce drug prices

Government 114

Government 114

European Pharmaceutical Review

APRIL 30, 2024

The World Health Organization (WHO) has published a new draft guidance on mitigating nitrosamine contamination in pharmaceutical products. Manufacturers of excipients and APIs should be compliant with relevant WHO good manufacturing practice (GMP) guidelines” One of the key recommendations described the actions manufacturers should take upon identifying a case of nitrosamine contamination that is above acceptable limits.

Manufacturing 84

Manufacturing Pharmaceutical products Pharmaceutical 84

pharmaphorum

APRIL 30, 2024

Prime Medicine has been given the go-ahead by the FDA for the first human trial of its prime editing technology, which promises to deliver one-shot therapies for a range of severe genetic diseases.

FDA 105

FDA Medicine 105

MedCity News

APRIL 30, 2024

Here is a selection of recent executive hires, promotions and layoffs occurring across the healthcare industry. The post Healthcare Moves: A Monthly Summary of Hires and Layoffs appeared first on MedCity News.

Healthcare 88

Healthcare Healthcare Biopharma 88

Advertisement

Pharmaceutical Technology

APRIL 30, 2024

Unlock the potential of genetic modification with Precision Biosciences Inc's patented MTEM technology for precise editing of eukaryotic cells. Discover how this mitochondria-targeting engineered meganuclease is revolutionizing genetic research.

Engineering 78

Engineering 78

MedCity News

APRIL 30, 2024

With hospitals struggling to retain staff and value-based care shrinking healthcare revenues, health systems must look to technology resources to become more efficient, without losing sight of patient care or staff support. The post What’s Keeping Healthcare CIOs Up at Night: How Health Systems Automate Routine Phone Calls to Improve Workforce Effectiveness and Reduce Agent Burnout appeared first on MedCity News.

Healthcare 85

Healthcare Healthcare Patients 85

PharmaTimes

APRIL 30, 2024

GPT-4 is trained on datasets to offer eye-related advice, diagnosis and management suggestions

Doctors 109

Doctors Training Management 109

Pharmaceutical Technology

APRIL 30, 2024

The FDA granted accelerated approval for the drug back in September 2021 following positive Phase II trial data.

FDA 98

FDA 98

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

Pharmaceutical Commerce

APRIL 30, 2024

The complex will research solutions for manufacturing antibodies, mRNA applications, and more.

Manufacturing 105

Manufacturing 105

PharmaTech

APRIL 30, 2024

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

69

69

PharmaTimes

APRIL 30, 2024

An estimated 50% of human genes follow a circadian cycle, many of which are active in the liver

98

98

MedCity News

APRIL 30, 2024

Shift flexibility is critical to nurse satisfaction. The post Travel Nursing Won’t Solve the Staffing Shortage, But Reimagining Staffing Models Might appeared first on MedCity News.

59

59

Advertisement

Distribution

Pharmaceutical Commerce

APRIL 30, 2024

The latest news for pharma industry insiders.

Pharma 105

Pharma Medical 105

Clarify Health

APRIL 30, 2024

This is part one of our three-part series about how health plan leaders can leverage healthcare claims data to reduce costs , strategically grow their networks , provide best-in-class member services , and enhance outcomes for their members. R ising healthcare costs pressure health plans to find creative ways to reduce costs without compromising patient outcomes.

Healthcare 52

Healthcare Healthcare Education Management 52

Contrarian Sales Techniques

APRIL 30, 2024

Happy Labor Day! Today isn't just about snagging that last summer barbecue or hitting the beach—it’s about giving it up for the everyday heroes of the American workforce. Way back in the late 19th century, Labor Day started as a shout-out to the grunt and grind that built this country, and it's still a nod to the sweat that keeps it running. This holiday is our chance to kick back, sure, but it’s also the perfect time to tip our hats to the achievements of workers and the labor movement that’s f

Sales 52

Sales Safety 52

Spotio

APRIL 30, 2024

Sales reps in the manufacturing industry face unique challenges. Competition is fierce, buyers often come to the table with preconceived notions—notions that must be adjusted to make sales—and prices continue to plummet in an attempt to win business. We’re here to tell you that success is possible in this space. But you need to train your reps to overcome the challenges in front of them and close deals.

Training 52

Training Manufacturing Sales Prospecting 52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales